Taipei, June 5 (CNA) The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
03/19/2024 11:33 AM - Business
Furloughed workers down over 500 as manufacturers' orders stabilize
03/19/2024 11:32 AM - Society
Cool, rainy weather for northern Taiwan, with lows of 13℃: CWA
03/19/2024 10:55 AM - Business
U.S. dollar higher in Taipei trading
03/19/2024 10:37 AM - Business
Taiwan shares open lower
03/19/2024 09:08 AM